Answers are grounded in this paper and cite their sources.
The increasing occurrence of pharmaceutical contaminants in aquatic environments requires the development of efficient and sustainable treatment technologies. In this study, a silane-functionalized oxygen-vacancy-engineered V o -TiO 2 /B-g-C 3 N 4 heterostructure composite was constructed for visible-light-assisted peroxymonosulfate (PMS) activation toward moxifloxacin degradation. The analyses demonstrated successful integration of V o -TiO 2 and B-g-C 3 N 4 with silane-derived surface modification, accompanied by enhanced visible-light absorption, defect-related electronic states, and improved charge-transfer characteristics. The V o -TiO 2 /B-g-C 3 N 4 -Silane composite exhibited superior degradation performance compared with individual components, achieving complete moxifloxacin removal within 75 min under optimized conditions (catalyst dosage: 0.4 g/L; PMS concentration: 0.15 mM; pH 6.5). Radical scavenging experiments combined with ESR spin-trapping analysis confirmed the involvement of SO 4 •- , • OH, and • O 2 − in the degradation process. LC-MS analysis revealed multiple transformation pathways, including hydroxylation, defluorination, side-chain cleavage, and functional group modification. Toxicity assessments based on hemolytic activity, brine shrimp lethality, and mutagenicity assays demonstrated reduced biological toxicity after photocatalytic treatment. Moreover, the catalyst maintained approximately 90% degradation efficiency after eight consecutive cycles, with preserved crystalline structure after reuse. This work provides insights into the design of defect-engineered semiconductor composites for visible-light-driven PMS activation and pharmaceutical pollutant transformation.
No takes yet. Share an insight, caveat, or question.
Kanjal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: